Speaker Engagements

Our senior experts are available for keynotes and panel contributions, offering deep insights across drug development.

Engagements can be arranged on a paid or pro bono basis depending on the event’s mission.

Examples of our engagements include

April 2025

RareGeniX Panel Discussion and Networking Event, hosted by cpl Life Sciences & TOPRA at The Royal Society of Chemistry, London.

The RareGeniX team discussed the latest hot topics in Quality, Manufacturing, Regulatory, Patient Engagement and Clinical Considerations to Accelerate New Medicines to the Clinic. Thank you to our sponsors and collaborators cpl Life Sciences and TOPRA and all attendees for making this entertaining debate, fresh, energetic and fun!

June 2025

RareGeniX’s Chief Medical Officer Dr Dmitry Zamoryakhin and Patient Engagement Lead Keith Berelowitz met new and existing clients at BIO International, Boston.

Subscribe to our Linked In page to find out where you can meet us in person or simply email info@RareGeniXConsulting.com

Sep 2025

RareGeniX’s patient engagement lead Keith Berelowitz spoke at Patient Empowerment 25 alongside MHRA’s Chief Executive Office Lawrence Tallon

Oct 2025

TOPRA Symposium in Berlin, Germany.

RareGeniX’s Dr Dima Al Hadithi, Dr Christine Grew and Keith Berelowitz led a panel discussion alongside regulators from Germany & EMA [Dr. Ralf Sanzenbacher (PEI), Dr. Jens Reinhardt (European Medicines Agency)] to deliver a human medicines discussion entitled ‘From Barrier to Bridge: Practical Strategies for Successful Advanced Therapy Medicinal Product (ATMP) Development’ providing actionable insights for those developing ATMPs.

Nov 2025

CMC Partner Dima Al Hadithi’s spoke at GenScript’s Biotech Global Forum advancing dialogue on regulatory, CMC, clinical development and investment in the field of advanced therapies.

A great write up of the session in Pharmaceutical Technology Early planning, outsourcing and digitalisation to break down CGT CMC barriers – Pharmaceutical Technology

Read Article

Nov 2025

RareGenix’s Quality Partner Ian Pardo spoke at “GMP meets Development – GMP and FDA Compliance in Pharmaceutical
Development and IMP Manufacturing” in Heidelberg.

Ian delivered three sessions on

– Qualification and Validation for IMPs

– Cleaning Validation in
Pharmaceutical Development

– A Data Integrity Deep Dive Workshop focused on ALCOA+ in day-to-day operations and audit/inspection practice.

Client Testimonials

"Thanks for your excellent report, it was extremely helpful in shaping both our decision-making and how we position our asset. RareGeniX's support was instrumental in helping us move forward to the next stage"
Japanese Developer
Clinical Stage Biotech
"I could only get so far with ChatGPT. RareGeniX’s advice, regulatory road map and clinical development plan are exactly what I needed."
CEO and Ophthalmic Surgeon

Contact us today to discuss how RareGenix Consulting can support your development goals.

Advancement of Life-Changing Therapeutic Medicines for Rare Disease

Contact

Feel free to reach out if you want to collaborate with us, or simply chat.

© 2024 RareGeniX Consulting Limited | All Rights Reserved